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Among the malignancies, colorectal cancer ranks fourth in incidence in Brazil. The main
prognostic measure is related to the amount of affected lymph nodes. Thus, many studies
try  to correlate the number of extracted lymph nodes, with the probability of obtaining
positive nodes.
Study objectives: Determine whether dissection ≥12 lymph nodes increases probability of
ﬁnding neoplastic involvement in relation to resection of fewer. Assess the presence of
angiolymphatic invasion; perineural and intracelluar mucin and correlate it with tumor
differentiation and TNM classiﬁcation. Correlate the average of positive nodes with angi-
olymphatic and perineural involvement.
Methods: Pathological reports of patients operated for CRC from 1997 to 2013 were analyzed.
A  probability (p) less than 0.05 was considered to indicate statistical signiﬁcance.
Results: Median of lymph nodes sent to analysis was 12 nodes. Average number of lymph
nodes affected was higher when a number ≥12 lymph nodes were dissected (p = 0.001)
(Kruskal–Wallis). There was positive association between average of affected lymph nodes
and  presence of angiolymphatic (p < 0.0001) or perineural invasion (p = 0.024). Angiolym-
phatic and intracellular mucin are less present in well-differentiated adenocarcinomas.
Perineural and angiolymphatic were more present in T4 stages.
Conclusions: Dissection ≥12 lymph nodes increases chances of ﬁnding positive nodes. There
is  relation between angiolymphatic invasion; perineural and intracellular mucin and type
of  tumor differentiation, as well as TNM classiﬁcation. Average number of lymph nodes
affected was higher in presence of perineural or angiolymphatic invasion.©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. Thisis  an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Número  de  Linfonodos  Dissecados  no  Câncer  Colorretal  e  Probabilidade
de  Nodos  Positivos,  Invasão  Angiolinfática,  Perineural  e  Mucina
Intracelular  em  Servic¸o de  Referência
Palavras-chave:
Neoplasias colorretais
Linfonodos
Excisão de linfonodo
r  e  s  u  m  o
Dentre as neoplasias malignas, o câncer colorretal ocupa o quarto lugar em incidência no
Brasil. Uma das principais medidas de prognóstico está relacionada à quantidade de linfon-
odos acometidos. Sendo assim, muitos trabalhos estudam meios de correlacionar o número
de  linfonodos dissecados, com a probabilidade de se obterem linfonodos positivos.
Objetivos do estudo: Determinar se a dissecc¸ão ≥ 12 linfonodos aumenta a probabilidade de
se  encontrar acometimento neoplásico nos mesmos em relac¸ão à menor ressecc¸ão. Avaliar
a  presenc¸a de invasão angiolinfática; perineural e mucina intracelular e correlacioná-la com
diferenciac¸ão tumoral e classiﬁcac¸ão TNM. Correlacionar a média de nodos positivos com
acometimento angiolinfático e perineural.
Métodos: Foram analisados laudos anatomopatológicos de pacientes operados por câncer
colorretal (CCR) de 1997 a 2013. A probabilidade (p) menor que 0,05 foi considerada para
indicar signiﬁcância estatística.
Resultados: A média de linfonodos comprometidos foi maior quando um número ≥ 12 lin-
fonodos foram dissecados (p = 0,001) (Kruskal-Wallis). Houve associac¸ão positiva entre a
média de linfonodos afetados e a presenc¸a de invasão angiolinfática (p < 0,0001) ou perineu-
ral  (p = 0,024). A invasão angiolinfática e a mucina intracelular estavam menos presentes em
adenocarcinomas bem diferenciados. Invasão perineural e angiolinfática estiveram mais
presentes nos estádios T4.
Conclusões: A dissecc¸ão ≥ 12 linfonodos aumenta as chances de se encontrar nodo posi-
tivo. Existe relac¸ão entre invasão angiolinfática; perineural e mucina intracelular e o tipo de
diferenciac¸ão tumoral, bem como a classiﬁcac¸ão TNM. A média de linfonodos comprometi-
dos  foi maior na presenc¸a de invasão perineural ou angiolinfática.
©  2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este
e´  um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://creativecommons.org/
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olorectal cancer (CRC) is the fourth most frequent malig-
ancy in Brazil. It is estimated that in 2014, 32,600 new CRC
ases were diagnosed in this country. Of these, 15,070 were
ale and 17,530 were female subjects, corresponding to an
stimated risk of 15.44 and 17.24 cases per 100,000 population
or men  and women, respectively.1 In the world, CRC is the
hird most prevalent cancer; and in Western countries, is the
econd leading cause of cancer-related deaths.2
Due to the high prevalence of CRC, a great emphasis is given
o the publication of studies to evaluate the characteristics of
his disease, as well as the determinant factors of its course.
n 1932, Dukes proposed that the depth of tumor invasion in
he colonic wall, lymph node involvement, and the presence
f metastases would be determining factors for tumor staging
nd, to date, these are considered the most important ﬁndings
or disease prognosis.3
In recent years, the relationship between the number of
esected lymph nodes and those compromised by CRC, i.e.
he lymph node ratio (LNR), has been subject to evaluation
n several studies. Research evaluating LNR in patients with
rimary tumors of the stomach, bladder, breast, and pancreas
evealed the existence of a relationship between the propor-
ion of positive lymph nodes, disease-free survival, and overall
urvival.4–8licenses/by-nc-nd/4.0/).
The minimum number of lymph nodes that must be diss-
ected has been the subject of some studies, and some of them
suggested 12 as the minimum number of lymph nodes to be
dissected.9,10 This is also the number that has been accepted
by the American Joint Committee on Cancer and the World
Congress of Gastroenterology in order to stratify the patients
as free of metastatic disease. In addition to these organi-
zations, in 2007 the Association of Coloproctology of Great
Britain and Ireland also started recommending an average of
12 lymph nodes.11
Lymph node dissection in CRC cases managed to establish
itself as an important method for prognostic evaluation. Thus,
it has become critical that more  studies be published in order
to evaluate this method, so that one can determine more  pre-
cisely its true potential in relation to what it can represent in
terms of knowledge and prognosis with respect to CRC.
The objectives of this study are set forth below.
Primary objective
(1) To determine if the dissection of ≥12 lymph nodes
increases the probability of ﬁnding neoplastic involvement
in these structures, compared with a lesser number of
resected lymph nodes.
Secondary objectives
(2) To evaluate the presence of angiolymphatic and perineural
invasion and intracellular mucin and to correlate the ﬁnd-
ings with tumor differentiation and TNM classiﬁcation;
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(3) To correlate the average of positive nodes with angiolym-
phatic and perineural involvement.
Methods
All pathology reports of surgical specimens of patients under-
going elective or non-elective surgery for CRC from January
1997 to December 2013, operated in the Hospital Nossa Sen-
hora da Conceic¸ão, in the city of Tubarao – SC, were analyzed
in a case-series, cross-sectional, retrospective study. The data
were selected with the use of a collection instrument devel-
oped by the authors, which included the following variables:
date of the pathology report, patient’ s genre, year, patient’
s age, tumor location, size of the surgical specimen, TNM
classiﬁcation, Astler–Coller classiﬁcation, type of surgery per-
formed, number of dissected lymph nodes, number of affected
lymph nodes, tumor differentiation, presence of intracellular
mucin, angiolymphatic invasion, and perineural invasion.
All pathology reports of surgical specimens diagnosed with
colorectal adenocarcinoma, classiﬁed as belonging to any
TNM classiﬁcation stage, were included in this study. Patients
who met  the following criteria were excluded:
1. CRC diagnosis associated with inﬂammatory bowel disease
(Crohn’s disease or ulcerative colitis).
2. Neoplasms with a histopathologic diagnosis not compati-
ble with adenocarcinoma.
3. Patients undergoing neoadjuvant therapy.
All patients were operated on by laparotomy or
laparoscopy, and the surgical treatment chosen followed
the conventional pattern of resection, including lym-
phadenectomy and, in the case of rectal tumors, mesorectal
resection.
The study was approved by the Research Ethics Committee
(CEP) of the Universidade do Sul de Santa Catarina (proto-
col number 13.004.4.01.III). The study followed the regulations
of Resolution 466 of 2012. Thanks to the absence of a direct
contact with patients in the study, the free and informed con-
sent term (FICT) was not necessary. Consent of the institutions
involved for the use of the data was obtained.
Data were cataloged in the form of an electronic spread-
sheet (Microsoft Excel) and transferred for statistical analysis
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to EpiInfo/SPSS version 18 software. Qualitative variables were
described by absolute and relative frequencies, and quantita-
tive variables were described as a mean, median and standard
deviation. Statistical analyses were performed using the chi-
squared test, Student’s t-test, Kruskal–Wallis test and Fisher
test with Monte Carlo correction, as needed. The level of sig-
niﬁcance was set at 5%.
Results
In total, the study involved 290 patients who underwent sur-
gical treatment for CRC resection between 1997 and 2013. The
mean age was 61.9 (SD = 13.4) years and the median age was 63
years. Male subjects were slightly more  affected versus female
subjects. Of all patients, 149 (51.4%) were men. The mean age
of the patients at the time of surgery was 62.8 years for men
and 61.0 years for women. T3 is the most prevalent tumor stag-
ing among patients (229 cases, i.e. 73% of the total). Of  the 290
patients, 151 (52.10%) had ≥12 lymph nodes dissected. The
median of the number of lymph nodes sent for histopatholog-
ical analysis was 12 (range: 1–53). Fig. 1 illustrates the median
for lymph nodes dissected over the studied years.
Of all the patients studied, only 17 had metastasis (M1)
by TNM classiﬁcation at the time of surgery, represent-
ing 5.9%. The most common tumor differentiation was a
well-differentiated adenocarcinoma for 212 patients (73.1%).
Table 1 lists the information related to the following variables:
gender, anatomical site, tumor invasion (T), affected regional
lymph nodes (N), distant metastasis (M)  and tumor differen-
tiation. Table 2 lists the proportion of positive lymph nodes,
according to the number of analyzed ganglia.
The study showed that when ≥12 lymph nodes are dissec-
ted, the probability of ﬁnding a positive node is higher versus
a smaller number of nodes resected (p = 0.001) (Table 3).
The probability of an angiolymphatic invasion was lower in
the well-differentiated type than in moderately differentiated
and undifferentiated types (p = 0.0005). The well-differentiated
type was that that presented least intracellular mucin in rela-
tion to moderately differentiated and undifferentiated types
(p = 0.001) (Fisher’ s exact test with Monte Carlo correction).
Perineural invasion was signiﬁcantly more  present in cases
of moderately differentiated adenocarcinoma versus other
subtypes (p < 0.01) (Fisher test). This same poor prognosis
sected nodes
 dissected nodes
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 nodes over the years.
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Table 1 – General characteristics of the study sample.
Variable Total <12 resected nodes ≥12 resected nodes p-Value
n % n % n %
Gender
Male 149 51.4 69  46.31 80 53.69 0.570
Female 141 48.6 70 49.65 71 50.35
Anatomic location
Colon, unspeciﬁed 108 37.2 54 50.00 54 50.00 0.475
Rectosigmoid 82 28.3 39 47.56 43 52.44
Right colon 33 11.4 11 33.33 22 66.67
Colon and rectum 21 7.2 12 57.14 9 42.86
Sigmoid 16 5.5 9 56.25 7 43.75
Rectum 11 3.8 7 63.64 4 36.36
Left colon 9 3.1 5 55.56 4 44.44
Large intestine and anus 5 1.7 1 20.00 4 80.00
Transverse colon 4 1.4 1 25.00 3 75.00
Left colon and sigmoid 1 0.3 0 0.00 1 100.00
Tumor invasion (T)
T0 0 0 0.020
T1 6 2.1 4  66.67 2 33.33
T2 26 9 19 73.08 7 26.92
T3 229 79 106 46.29 123 53.71
T4 29 10 10 34.48 19 65.52
Affected regional lymph nodes (N)
N0 154 53.1 82 53.25 72 46.75 <0.001
N1 67 23.1 41 61.19 26 38.81
N2 68 23.4 15 22.06 53 77.94
N3 1 0.3 1  100.00 0 0.00
Distant metastasis (M)
MX 273 94.1 135 49.45 138 50.55 0.038
M0 0 0 0 0
M1 17 5.9 4 23.53 13 76.47
Tumor differentiation
Well differentiated 212 73.1 101 47.64 111 52.36 0.184
Moderately differentiated 42 14.5 21 50.00 21 50.00
Undifferentiated 13 4.5 3 23.08 10 76.92
Othera 23 7.9 14 60.87 9 39.13
a Ranked among well- to moderately undifferentiated (n = 22) and adenomucinous (n = 1).
Table 2 – Proportion of positive lymph nodes according to the number of ganglia analyzed.
Number of nodes
examined
Number of
patients
Patients with
+nodes
% +nodes Mean of +nodes Standard
deviation
0–4 36 14 38.9 0.78 1.10
5–9 71 29 40.8 1.21 1.98
10–14 75 33 44 2.20 3.53
15–19 53 29 54.7 4.28 5.11
20–24 30 15 50 2.23 4.16
25–29 15 10 66.7 7.20 8.89
≥30 10 5 50 8.50 11.68
Table 3 – Mean of positive nodes in connection with the dissection of 12 or more  lymph nodes.
Lymph nodes Patients Compromised
lymph nodes
Mean  Variance Standard
deviation
<12 139 179 1.2878a 4.8731 2.2075
≥12 151 587 3.8874a 35.7139 5.9761
a p = 0.001 (Kruskal–Wallis).
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Table 4 – Comparison between the mean number of
compromised lymph nodes and the presence of
perineural or angiolymphatic invasion.
Mean of
compromised
nodes
Number Standard
deviation
Perineural invasion
present
5.28a 18 7.25
Perineural invasion
absent
2.59a 247 4.63
Angiolymphatic
invasion present
4.19b 112 5.99
Angiolymphatic
invasion absent
1.74b 153 3.54
a p = 0.024.
However, considering the results in Table 3, it appears thatb p < 0.0001.
factor was also more  prevalent in T4 (24%) compared to T3
(5.6%), T2 (0%) and T1 (0%) staging (p = 0.013). Perineural inva-
sion was also more  present when there was at least one
affected regional lymph node (N1) (10.9%) or four or more
affected lymph nodes (N2) (10.8%) versus lymph nodes with
no involvement (N0) (2.9%) (p = 0.028).
Angiolymphatic invasion was signiﬁcantly more  present
when the tumor was at T4 stage (72%) versus a lesser degree
of invasion (p = 0.01). Regarding the presence or absence of
metastasis, the angiolymphatic invasion was more  preva-
lent in cases with distant metastasis (40.2%) (chi-squared
test = 0.006246). Positive lymph node involvement also showed
a higher prevalence of angiolymphatic invasion than in the
absence of affected lymph nodes (N0, 29.4%), (N1, 53.1%), (N2,
58.5%) (p = 0.0001).
The presence of intracellular mucin had a signiﬁcant cor-
relation only on tumor differentiation, being more  present in
undifferentiated adenocarcinoma (30.8%) (p = 0.005).
In the comparison between the mean number of affected
lymph nodes with perineural or angiolymphatic invasion, it
was observed an increase in the mean of positive nodes when
these factors are present (Table 4).The most commonly performed surgeries in the study and
the percentage of compromised ganglia by type of surgery are
listed in Table 5.
Table 5 – Percentage of number of axillary nodes according to t
Type of resection Number of
patients
Patients w
node+
Rectosigmoidectomy 190 88 
Total colectomy 20 6 
Hemicolectomy, unspeciﬁed 20 13 
Amputation of rectum 17 8 
Colectomy, unspeciﬁed 14 7 
Hemicolectomy 10 3 
Left sigmoidectomy 7 4 
Right hemicolectomy 6 3 
Transversectomy 3 1 
Proctocolectomy 3 2  1 6;3  6(4):220–226
Discussion
According to the Centers for Disease Control and Prevention
(CDC), the majority of patients diagnosed with CRC in the
United States belong to the male gender, with a percentage
of 51.8% (70,099 patients) in a population of 135,260 patients
diagnosed in the year 2011 (the most recent year available).12
Similar to the US data, this study also found a greater preva-
lence of men, with 51.4%. By comparison, the Brazilian data
cite an estimated 32,600 new cases of CRC diagnosed in 2014.1
This study showed that the mean age at the time of tumor
resection is approximately 61 years. When one adds to this
the fact that, in our sample, most of the patients were seen
in advanced stages, both in the TNM classiﬁcation, with a
prevalence of T3 and in the Astler–Coller classiﬁcation, with
B2 class, one can verify that the diagnostic of CRC is not timely
obtained. Thus, it should be noted the importance of an ade-
quate CRC screening, especially since this tumor has a slow
evolution, allowing considerable time for its detection and
treatment.
Other studies have also presented T3 and N0 stages as the
most prevalent,13–15 as is the case in the study by Oliveira et al.
of 74 patients with colorectal cancer; in this study, 62.1% of
patients had a T3 classiﬁcation and 59.5% were in N0 stage.
For the sake of comparison, Jacomo et al. studied 90 patients
with rectal cancer, excluding patients with colonic tumor, with
similar ﬁndings for T3 (55.5%) and N0 (67.7%) stages.
Based on collected data, one can trace a curve that shows
the lymph node dissection over the years – a valuable data to
verify the performance of the health service in the area since
lymph node collection has been used as a measuring instru-
ment of medical care quality.16 Thus, it is possible to report
that in the last four years the median for extracted lymph
nodes remained above the minimum number indicated. This
monitoring becomes important when we consider that Lanza
et al. concluded that the evaluation of a few regional lymph
nodes can result in an understaging of N0 tumors.17
The median of resected lymph nodes was 12, which agrees
with the number proposed by various agencies and studies.9,11only 52.07% of patients underwent resection of >12 lymph
nodes. Thus, the use of the median as the sole form of assess-
ment is not fully indicated, since a large part (47.93%) of
he type of surgery.
ith % Mean of
ganglia+
Standard
deviation
46.3 2.77 4.98
30 0.85 2.25
65 4.4 7.01
47.1 2.76 4.01
50 2.36 3.43
30 0.7 1.16
57.1 1.43 1.62
50 3.5 4.72
33.3 2.67 4.62
66.7 2.67 3.79
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atients had less than 12 of their lymph nodes resected. Thus,
esides the median, we  should also assess the percentage of
atients undergoing resection of 12 or more  lymph nodes.
We could not set the real reason for the numerical decline
f lymph node dissections in 2002 and 2008, shown in ﬁg-
re. However, one possible explanation is the fact that the
ast majority of surgeries performed in this study consisted
f rectosigmoidectomy procedures. One study which exam-
ned 388 patients with CRC showed a greater tendency for the
esection of fewer lymph nodes in the distal regions of the
olon, compared to what occurs more  proximal regions.18
But it becomes clear the importance of such monitoring for
he resection of lymph nodes. Baxter et al., in a population-
ased study, found that in 2001 the majority of patients with
RC were still receiving an inadequate lymph node evalua-
ion in the United States, where only 37% of the patients were
aving ≥12 lymph nodes resected.9
Still with regard to the number of dissected lymph nodes,
his study demonstrated that when one gets ≥12 nodes, it
ecomes more  likely the ﬁnding of a node affected by the
umor. However, Yoshimatsu et al. report that ≥9 lymph nodes
ould be the minimum number to be obtained in the case of
olorectal tumors with a B classiﬁcation in the Duke’s system
 the stage most commonly found so that one could assess
he negativity of lymph node involvement.10 On the other
and, Kim et al., by dividing the lymph node resection into 0–4,
–9, and 10–14 groups, found a signiﬁcantly higher probabil-
ty of ﬁnding positive nodes from a number of 10–14 resected
odes19 – a very similar result to that obtained in the present
tudy. Thus, a resection of 12 lymph nodes is suggested, tak-
ng into account that a three times larger mean number of
ositive lymph nodes was obtained when ≥12 lymph nodes
ere resected. This ﬁnding underlines the importance of an
ccurate lymph node resection, by allowing a greater number
f detections of nodal involvement, which would agree with
revious studies and with what has been proposed by the main
uidelines.9–11
CRC may exhibit some features that are associated with
 poor prognosis, such as perineural invasion, angiolym-
hatic invasion and the presence of intracellular mucin,20–22
lthough some authors also comment on the need for more
tudies on the prognostic value of such elements.23 In our
ample, it was found that in the well-differentiated sub-
ype there was a decrease in angiolymphatic invasion. This
act reveals an inverse association between these variables,
uggesting that a neoplasia with a higher degree of differenti-
tion is less likely to progress with involvement of blood and
ymph vessels. Intracellular mucin was also less prevalent in
uch subtype, which could be envisaged when one takes into
ccount the expectation of a less aggressive behavior with a
ell-differentiated tumor.
The ﬁnding of a correlation of intracellular mucin solely
ith tumor differentiation may suggest that this characteris-
ic is not related to the level of invasiveness, but only with
he differentiation of the neoplastic cells. However, this still
emains a poor prognostic indicator, due to the association
ith poorly differentiated adenocarcinoma.
We also observed that the mean number of compro-
ised lymph nodes was signiﬁcantly higher in cases with
erineural or angiolymphatic invasion; however, during our;3 6(4):220–226 225
database survey, no studies evaluating these associations were
found.
The site speciﬁcally most affected by CRC was the rec-
tosigmoid, despite the large number of patients whose reports
did not indicate the tumor site, which affected the analy-
sis of this variable. However, by checking the most common
type of surgery, it was observed that rectossigmoidectomy was
the most common procedure, indicating that this was indeed
the preferred site of the neoplasm. Saad-Hossne et al. also
demonstrated that sigmoid and rectum were the most com-
mon sites.24
Conclusion
This study agrees with other similar studies; we  could demon-
strate that the dissection of ≥12 lymph nodes increases the
chances of ﬁnding a positive node compared to the dissection
of fewer nodes. It was also observed a relationship between
angiolymphatic invasion, perineural invasion and intracellu-
lar mucin and the type of tumor differentiation and TNM
classiﬁcation. In addition, another ﬁnding was that the mean
number of compromised lymph nodes is signiﬁcantly higher
when a perineural or angiolymphatic invasion is present.
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